Table 2.

Perceived impact of COVID-19 pandemic on access to care and experience of telehealth.

	Type 1 diabetes (n = 763) % (n)	Type 2 diabetes (n = 619) % (n)
Diabetes appointment status: of those with appointments scheduled since pandemic
All appts cancelled or postponed	39.3% (196)	42.7% (178)
≥ 1 appts switch to telehealth	43.1% (215)	37.6% (157)
≥ 1 appts switched to telephone	24.4% (124)	24.0% (101)
≥ 1 appts switched to video	23.0% (117)	16.1% (67)
Telephone appointment experience
Lower satisfaction	43.9% (54)	45.0% (45)
No change in satisfaction	45.5% (56)	39.0% (39)
Higher satisfaction	10.6% (13)	16.0% (16)
Video appointment experience
Lower satisfaction	38.4% (45)	40.4% (27)
No change in satisfaction	47.9% (56)	43.3% (29)
Higher satisfaction	13.7% (16)	16.5% (11)
Number reporting access concerns
Food to maintain usual diet	30.9% (236)	35.5% (220)
Diabetes supplies	15.2% (116)	8.9% (55)
Contact with health care team	11.1% (85)	9.0% (56)
Diabetes medications	6.6% (50)	8.6% (53)
Labs/tests cancelled or postponed	30.9% (232)	31.3% (190)